AZD 2066 hydrate - KKL Med Inc.

您当前的位置：

AZD 2066 hydrate

目录号 : KM10491 纯度 : 98%

Data Sheet 产品使用指南

AZD 2066 hydrate 是一种选择性的，具有口服活性和可透过血脑屏障的 mGluR5 的拮抗剂。AZD 2066 hydrate 具有抗伤害作用。

规格	价格	是否有货
5mg		In-stock
10mg	询价	In-stock
50mg	询价	In-stock

加入购物车大包装询价

Other Forms of Rapamycin:

Ginkgolide J In-stock
Ginkgolide K In-stock
THK-5470 In-stock
NH-3 In-stock
Velufenacin In-stock

KKL Med 的所有产品和服务仅用于科学研究，不能被用于人体，兽医，我们也不向个人提供产品和服务。

生物活性

AZD 2066 hydrate is a selective, orally active and brain-penetrant antagonist of mGluR5. AZD 2066 hydrate has antinociception effects.

体外研究

AZD 2066 (1-10 μM) inhibits Ca response, with IC₅₀s of 27.2±9.1, 3.56±0.52, 96.2±17.8, and 380±78.0 nM in mGlu5/HEK cells and striatal, hippocampal, and cortical cultures respectively.
AZD 2066 (1-10 μM) inhibits the oscillatory Ca response which induced by bath application of DHPG, and blocks either DHPG or Quis eﬀects in mGlu5/HEK cells.
AZD 2066 (1-10 μM) has less eﬀective in striatal neurons.

体内研究

AZD 2066 (0.03-30 mg/kg; p.o.) shows discriminative effects in rats.

Animal Model:	Male Wistar rats (weighing 240-250 g)
Dosage:	0.03, 0.1, 0.3, 1, 3, 10, 30 mg/kg
Administration:	P.o. (60 minutes after administration)
Result:	Caused full and dose-dependent AZD9272-appropriate responding.